Shots: XBiotech to receive $750M up front and additional milestones upon certain commercialization authorizations. Janssen to get all rights for bermekimab and will conduct clinical program following the completion […]readmore
Tags : Acquire
Shots: Sanofi to acquire Synthrox in all-cash transactions at $68/share, making a total deal value $2.5B with a premium of 172% to Synthorx’s closing price on December 6, 2019. The […]readmore
1. Sage Therapeutics Reports Results of SAGE-217 in P-III MOUNTAIN Study for Major Depressive Disorders Published: Dec 05, 2019 | Tags: Sage Therapeutics, Reports, Results, SAGE-217, P-III, MOUNTAIN Study, Major […]readmore
Shots: Cerecor acquires Aevi Genomic Medicine in an all-stock transaction for $16.1M upfront + $2M (cash/ stock) as CVR on the enrollment of P-II study of AEVI-002, AEVI-006 or AEVI-007 […]readmore
Shots: STADA to acquire Biopharma’s pharmaceutical prescription and consumer health business including local manufacturing operations and ~300 new staff. Biopharma will retain its blood plasma-based business and will focus on […]readmore
Shots: Astellas to acquire Audentes in all-cash transactions at $6/share making a total deal value as $3B with a premium of 110% to Audentes’ closing share price of US$28.61 on […]readmore
Shots: Baxter signs an agreement with Sanofi to acquire Seprafilm Adhesion Barrier and related assets for $350M with expected closure of transaction in Q1’20 The focus of the acquisition to […]readmore
Shots: Novartis to acquire The Medicine Company in all-cash transaction for $85/share at a 24% 1-day premium, making fully diluted equity value as $7.7B and a total deal value as […]readmore
Shots: Alkermes acquires Rodin in all cash transaction, making the total deal value as $950M which include $100M upfront in cash and up to $850M as clinical, regulatory and commercial […]readmore
Shots: Aerie to acquire Avizorex (AVX) in an all-cash transaction. Avizorex to receive $10M up front, development & regulatory milestones with royalties in sales of the approved product in its […]readmore